Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Apollo Hospitals Enterprise Limited, together with its subsidiaries, engages in the provision of healthcare services in India and internationally. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, orthopedics, oncology, neurosciences, emergency, robotic surgery, and transplants; and cardiology, neurology, gastroenterology, dermatology, ophthalmology, pediatric, endocrinology, gynecology, urology, nephrology, pulmonology, rheumatology, neurosurgery, radiology, plastic-surgery, neonatology, vascular-surgery, psychiatry, dentistry, ear, nose, and throat care, as well as genomic medicines. The company also provides other services, such as project consultancy, health insurance, medical colleges, medvarsity for e-learning, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, specialized birthing centers, dialysis centers, cradle and fertility centers, diabetes management centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. Further, the company engages in the business of bio-banking of tissues. It serves through national retail healthcare centers and genomics institutes, as well as Apollo 24/7, a digital health mobile platform; and www.apollopharmacy.in, an online pharmacy. The company was incorporated in 1979 and is based in Chennai, India.

Revenue projections:

Revenue projections for APOLLOHOSP
Revenue projections for APOLLOHOSP

APOLLOHOSP's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.

Financial Ratios:

currentRatio 0.00000
forwardPE 53.70456
debtToEquity 93.13200
earningsGrowth 0.51800
revenueGrowth 0.13900
grossMargins 0.34704
operatingMargins 0.10438
trailingEps 91.44000
forwardEps 81.60000

Apollo Hospitals Enterprise Limited's forward PE ratio is too high, raising concerns that future price increases may be restricted and a correction could be imminent. It's essential to weigh this parameter carefully in conjunction with other fundamentals to get a clearer picture of the stock's valuation.
Apollo Hospitals Enterprise Limited's high debt-to-equity ratio reveals that the company is heavily reliant on debt for financing. This high level of leverage increases the risk of financial strain if profits decline or interest rates rise.
With positive growth in both earnings and revenue, APOLLOHOSP is expected to grow its business. These indicators highlight a strong financial outlook, with the company on track for continued expansion and increasing profitability.
APOLLOHOSP's forward EPS being lower than its trailing EPS indicates that the company's earnings are projected to decrease. This suggests that APOLLOHOSP may struggle to maintain profitability at previous levels, potentially affecting its financial outlook.

Price projections:

Price projections for APOLLOHOSP
Price projections for APOLLOHOSP

APOLLOHOSP's price projections have been revised downward over time, reflecting a shift in sentiment among analysts. The steady decline in projections points to a more cautious outlook on the company's future performance.

Insider Transactions:

Insider Transactions for APOLLOHOSP
Insider Transactions for APOLLOHOSP


APOLLOHOSP had 3 buy transactions, with market price at 6553.183268229167 per share.Throughout the period under consideration, no buy transactions were recorded.The increased selling activity around APOLLOHOSP's current price levels may indicate further downside risk. If this trend continues, the stock's price could face additional declines as selling pressure intensifies.

Recommendation changes over time:

Recommendations trend for APOLLOHOSP
Recommendations trend for APOLLOHOSP


Analysts' recent buy bias toward APOLLOHOSP suggests the stock is gaining favor as a strong investment choice. This optimism could drive more investors to see APOLLOHOSP as a smart place to invest, further bolstering confidence in the company's long-term growth and potential returns.